Mindfulness-oriented Recovery Enhancement (MORE) for Cancer Pain Relief

Last updated: September 10, 2024
Sponsor: Memorial Sloan Kettering Cancer Center
Overall Status: Active - Recruiting

Phase

2

Condition

Cancer Pain

Acute Pain

Chronic Pain

Treatment

Standard of Care for Pain Management

MORE treatments

Clinical Study ID

NCT05877521
23-082
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to evaluate whether or not mindfulness-based interventions/MBIs may help reduce chronic pain in participants who have cancer-related chronic pain. MBIs are therapeutic programs that use mindfulness meditation practices to help people focus on the present moment, as well as encourage acceptance of thoughts, emotions, and body sensations. The researchers think that an MBI treatment called Mindfulness-oriented Recovery Enhancement (MORE) may help people who are experiencing cancer-related chronic pain.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • English speaking

  • Age ≥ 18 years or older

  • A history of cancer with no restrictions placed on type of cancer

  • Determined to be either no-evidence of disease or stable oncological disease byreferring or study physicians/advanced practice providers

  • Having a pain (musculoskeletal, generalized, or neuropathic) rating of 4 or greaterin worst pain on a 0-10 numerical rating scale in the preceding week

  • Having had pain for at least 3 months and at least 15 days with pain in thepreceding 30 days

  • Willing to adhere to all study-related procedures, including randomization to one oftwo treatment arms: MORE or WLC

  • Ability to attend video-call session and a quiet/private location

Exclusion

Exclusion Criteria:

  • Active suicidality or schizophrenia

  • Plan to initiate palliative radiation or interventional pain procedure within thenext 12 weeks

  • Cognitive impairment preventing completing PRO independently or participate invirtual MORE as evaluated by study clinicians

Study Design

Total Participants: 76
Treatment Group(s): 2
Primary Treatment: Standard of Care for Pain Management
Phase: 2
Study Start date:
May 16, 2023
Estimated Completion Date:
May 16, 2027

Connect with a study center

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York 10065
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.